Precision in CLL: Technical Insights and Clinical Impact of TP53 and IGHV in the Era of Targeted Therapy

• Authors: MALČÍKOVÁ Jitka
• Year of publication: 2024
• Type: Conference abstract
• MU Faculty or unit: Central European Institute of Technology

Related projects

• National institute for cancer research
• A variety of TP53 aberrant states in the clinical and biological behavior of chronic lymphocytic leukemia cells